![Anne Nöldner](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Anne Nöldner
Keine laufenden Positionen mehr
Profil
Anne Nöldner worked as the Head of Research and Development at oncgnostics GmbH.
Ehemalige bekannte Positionen von Anne Nöldner
Unternehmen | Position | Ende |
---|---|---|
oncgnostics GmbH
![]() oncgnostics GmbH Medical SpecialtiesHealth Technology oncgnostics GmbH offers cervical cancer diagnostic products and services. It engages in applying tumor-specific DNA methylation markers for cancer diagnosis and screening. The firm develops, based on proprietary epigenetic biomarkers, molecular in vitro diagnostic tests for screening, follow-up care and therapeutic decisions in cancer diagnostics. The company was founded by Matthias Dürst, Kerstin Brox, Martina Schmitz and Alfred Hansel in February 2012 and is headquartered in Jena, Germany. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
oncgnostics GmbH
![]() oncgnostics GmbH Medical SpecialtiesHealth Technology oncgnostics GmbH offers cervical cancer diagnostic products and services. It engages in applying tumor-specific DNA methylation markers for cancer diagnosis and screening. The firm develops, based on proprietary epigenetic biomarkers, molecular in vitro diagnostic tests for screening, follow-up care and therapeutic decisions in cancer diagnostics. The company was founded by Matthias Dürst, Kerstin Brox, Martina Schmitz and Alfred Hansel in February 2012 and is headquartered in Jena, Germany. | Health Technology |